| GeneLibs

题目:: Development of dendritic-cell based prostate cancer vaccine.
作者:: Tjoa(B A),Murphy(G P)
状态:: 发布时间2000-10-11 , 更新时间 2007-11-15
期刊:: Immunol Lett
摘要:: Available treatments for metastatic prostate cancer have failed to demonstrate significant curative potential. Current efforts are now directed towards developments of novel strategies for the treatment of metastatic prostate cancer. Cancer immunotherapeutic strategies utilize patient immune system components to kill cancer cells. This review discusses progress in active specific immunotherapeutic approaches as potential alternative methods in the treatment of metastatic prostate cancer. One of the newest advances in cancer immunotherapy is the use of dendritic cells as the vehicle to deliver cancer antigens for an effective in vivo T cell activation. The development of dendritic cell-based prostate cancer vaccine, as well as results of several clinical trials in prostate cancer involving the administration of peptide-pulsed autologous dendritic cell pulsed are discussed.
语言:: eng
DOI:

文献库文献相关信息